Edition:
United States

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

2.26USD
4:00pm EDT
Change (% chg)

$-0.06 (-2.59%)
Prev Close
$2.32
Open
$2.33
Day's High
$2.34
Day's Low
$2.24
Volume
21,400
Avg. Vol
12,990
52-wk High
$5.55
52-wk Low
$1.75

Chart for

About

OncoMed Pharmaceuticals, Inc. (OncoMed) is a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing therapeutics that address the fundamental biology driving cancer's growth, resistance, recurrence and metastasis. The Company's therapeutic candidates and preclinical programs include... (more)

Overall

Beta: 1.72
Market Cap(Mil.): $89.32
Shares Outstanding(Mil.): 38.50
Dividend: --
Yield (%): --

Financials

  OMED.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -0.31 -- --
ROI: -15.61 1.50 12.72
ROE: -- 0.19 14.85

BRIEF-Oncomed Reports Q1 Loss Per Share $0.15

* ONCOMED ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

May 08 2018

Competitors

  Price Chg
Amgen, Inc. (AMGN.OQ) $207.21 +2.11
Astellas Pharma Inc (4503.T) ¥1,959 +1.50
AstraZeneca plc (AZN.L) 5,652.00 -18.00
Bayer AG (BAYGn.DE) €76.15 -0.37
Bayer AG (BAYE.F) -- --
Celgene Corporation (CELG.OQ) $87.56 -0.16
Roche Holding Ltd. (ROG.S) CHF233.00 -2.15
Roche Holding Ltd. (RO.S) CHF234.00 -1.40
GlaxoSmithKline plc (GSK.L) 1,522.80 -8.60
Johnson & Johnson (JNJ.N) $140.47 -2.41

Earnings vs. Estimates